Dr Julie-Anne White
Dr Julie-Anne White has recently been appointed as the Director Health Research and Enterprise Development for Deakin University.
Prior to this current position she was the Chief Executive Officer of BioMelbourne Network .
Julie-Anne holds a BSc. Pharmacology from the University of Adelaide, MSc. Neuroscience from the University of London and PhD in Psychopharmacology from the Institute of Psychiatry, University of London, England.
Julie-Anne has a broad base of scientific knowledge, both diverse and deep, with significant translational research and commercialisation experience within the biotech and pharma sector. She has a broad range of diverse commercial business and leadership experience from start-ups to large pharma within different geographic jurisdictions, therapeutic areas, manufacturing, R&D and commercialisation.
Julie-Anne has held the role of CEO/MD in several organisations including private and publicly listed companies and Co-operative Research Centres. Most recently, Julie-Anne has acted as Deloitte Private Business Advisor for the Federal Government Entrepreneur Program in the Medtech/Pharma /Biotech growth sector. Her portfolio for the Federal Government included 45 Biotech/Medtech Companies in Victoria, South Australia, Tasmania and Queensland. In this role she advised SMEs and industry bodies about government policies and strategy, acting as an interface between industry and government for the Medtech Pharma Sector.
Other key roles have been as CEO of BioGeelong and Deputy CEO of the CRC for Polymers. She also has experience as CEO of start-up companies Salus Technologies Ltd and Zingo TX Pty Ltd.
Dr Noel Chambers
Dr Chambers is the CEO of the National Foundation for Medical Research and Innovation (NFMRI).
He has more than 30 years experience in start-up companies, commercial research and biotechnology. Noel has been the CEO/Managing Director of both listed and unlisted biotechnology companies and has extensive experience with start-up biotechnology companies, technology transfer and spinning companies out of Universities and CRC’s.
In the early 90’s his patented discoveries in type II diabetes led to a commercial partnership where he lead a team of researchers at the University of Sydney and was presented the Royal Australian Chemical Institute’s Biota Award for Medicinal Chemistry. Noel has been Head of Research for an Australian healthcare company and Business Development Manager for a multinational life-science company where he was responsible for in-licensing and company acquisitions.
Noel is a serial entrepreneur. He established his first company providing aquatic educational services when he was a student building the business to employ more than 70 staff. He has developed and commercialised a number of software solutions and established a number of start-up companies and business units. Noel co-founded Centuris in 1999 and led the establishment of Research Australia Philanthropy from 2009 – 2012.
Noel was a member of the Federal Government’s Advisory Council for Intellectual Property (ACIP) from 2009-2014, advising the Federal Minister for Innovation, Industry, Science and Research and was Chair of the ACIP review into collaborations between Publicly Funded Research Organisations and Industry.